Infinity Pharmaceuticals, Inc. to Present At Needham Biotechnology & Medical Technology Conference

CAMBRIDGE, Mass., June 7, 2007 (PRIME NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI), an innovative cancer drug discovery and development company, today announced that Julian Adams, Ph.D., President and Chief Scientific Officer, will be presenting a company overview at the Sixth Annual Needham & Company, LLC Biotechnology & Medical Technology Conference being held June 13-14, 2007 in New York. Infinity’s presentation will take place on Thursday, June 14, 2007, at 10:30 a.m. EDT.

MORE ON THIS TOPIC